{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:32:01Z","timestamp":1780979521768,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.critrevonc.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T11:43:26Z","timestamp":1528717406000},"page":"96-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma"],"prefix":"10.1016","volume":"128","author":[{"given":"Ilhan","family":"Elmaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-4087","authenticated-orcid":false,"given":"Meric A.","family":"Altinoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/00207450701540062","article-title":"Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis\/myelinosis in vitro","volume":"117","author":"Altinoz","year":"2007","journal-title":"Int. J. Neurosci."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.06.004_bib0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12094-017-1613-6","article-title":"Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential","volume":"19","author":"Altinoz","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm.2546","article-title":"Reciprocal repression between P53 and TCTP","volume":"18","author":"Amson","year":"2011","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0020","first-page":"625","article-title":"Forty years of antipsychotic drug research\u2014from haloperidol to paliperidone--with Dr. Paul janssen","volume":"57","author":"Awouters","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/leu.2011.338","article-title":"Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells","volume":"26","author":"Bar-Natan","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.06.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122660","article-title":"Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect","volume":"10","author":"Beluzi","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/mol.62.2.210","article-title":"The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms","volume":"62","author":"Bertolesi","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.06.004_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/bjc.2017.230","article-title":"TCTP as a therapeutic target in melanoma treatment","volume":"117","author":"Boia-Ferreira","year":"2017","journal-title":"Br J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.06.004_bib0045","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","article-title":"Selective and cell-active inhibitors of the USP1\/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells","volume":"18","author":"Chen","year":"2011","journal-title":"Chem. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.06.004_bib0050","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.18632\/oncotarget.4307","article-title":"The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.06.004_bib0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/138945010791170833","article-title":"Targeting the p53-family in cancer and chemosensitivity: triple threat","volume":"11","author":"Chung","year":"2010","journal-title":"Curr. Drug. Targets"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044631","article-title":"Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen","volume":"7","author":"Covell","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2018.06.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2017.05.002","article-title":"Mitochondrial dysfunction in cancer: potential roles of ATF5 and the mitochondrial UPR","author":"Deng","year":"2017","journal-title":"Semin Cancer Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.06.004_bib0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(93)70284-Z","article-title":"Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach","volume":"29","author":"Driscoll","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"issue":"April 7","key":"10.1016\/j.critrevonc.2018.06.004_bib0075","doi-asserted-by":"crossref","first-page":"768","DOI":"10.7150\/ijbs.14718","article-title":"Inhibition of wnt\/\u03b2-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide","volume":"12","author":"Fako","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"March 3","key":"10.1016\/j.critrevonc.2018.06.004_bib0080","article-title":"Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data","volume":"11","author":"Fortney","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"Aug 10","key":"10.1016\/j.critrevonc.2018.06.004_bib0085","article-title":"USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy","volume":"12:91","author":"Garc\u00eda-Santisteban","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2018.06.004_bib0090","article-title":"The t-cell leukemia associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling","author":"Girardi","year":"2017","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.critrevonc.2018.06.004_bib0095","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1073\/pnas.80.16.5122","article-title":"Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists","volume":"80","author":"Gould","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.06.004_bib0100","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice","volume":"151","author":"Jandaghi","year":"2016","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000439550","article-title":"L-carnitine ameliorates cancer cachexia in mice partly via the carnitine palmitoyltransferase-associated PPAR-\u03b3 signaling pathway","volume":"38","author":"Jiang","year":"2015","journal-title":"Oncol. Res. Treat."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.06.004_bib0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1476-5381.2010.00923.x","article-title":"Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines","volume":"161","author":"Kast","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.06.004_bib0115","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0360-3016(86)90173-2","article-title":"Chemical modulation of bleomycin induced toxicity","volume":"12","author":"Kennedy","year":"1986","journal-title":"Int. J. Radiat. Oncol. Biol Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur J. Pharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.06.004_bib0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pflugers Arch."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.06.004_bib0130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/1097-0142(19820315)49:6<1178::AID-CNCR2820490619>3.0.CO;2-H","article-title":"Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity","volume":"49","author":"Krummel","year":"1982","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.06.004_bib0135","first-page":"2236","article-title":"Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells","volume":"46","author":"Lazo","year":"1986","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.06.004_bib0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0024-3205(85)90120-1","article-title":"Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin","volume":"36","author":"Lee","year":"1985","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2018.06.004_bib0150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.06.004_bib0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0022-4804(84)90120-3","article-title":"Inhibition of murine neuroblastoma growth by dopamine antagonists","volume":"36","author":"McGrath","year":"1984","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0160","first-page":"135","article-title":"Inhibition of human neuroblastoma by dopamine antagonists","volume":"98","author":"McGrath","year":"1985","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.critrevonc.2018.06.004_bib0165","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1535-7163.MCT-13-0103-T","article-title":"Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells","volume":"12","author":"Mistry","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2018.06.004_bib0170","first-page":"11","article-title":"Pimozide for schizophrenia or related psychoses","author":"Mothi","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/070674379504001008","article-title":"An overview of treatment in paranoia\/delusional disorder","volume":"40","author":"Munro","year":"1995","journal-title":"Can. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0180","first-page":"155","article-title":"Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients","volume":"67","author":"Neifeld","year":"1983","journal-title":"Cancer Treat. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.06.004_bib0185","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"issue":"7\u20138","key":"10.1016\/j.critrevonc.2018.06.004_bib0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1947601912466555","article-title":"The STAT5 inhibitor pimozide displays efficacy in models of acute myelogenous leukemia driven by FLT3 mutations","volume":"3","author":"Nelson","year":"2012","journal-title":"Genes Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.06.004_bib0195","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.18632\/oncotarget.3279","article-title":"FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia","volume":"6","author":"Nogami","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.06.004_bib0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1248\/yakushi.15-00262-1","article-title":"Possible involvement of insulin resistance in the progression of cancer cachexia in mice","volume":"136","author":"Ohsawa","year":"2016","journal-title":"Yakugaku Zasshi"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.06.004_bib0205","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.bbamem.2008.04.007","article-title":"Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane?","volume":"1778","author":"Oruch","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.06.004_bib0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1471-4159.1981.tb04488.x","article-title":"Alterations of phospholipid metabolism in rat cerebral cortex mince induced by cationic amphiphilic drugs","volume":"37","author":"Pappu","year":"1981","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.06.004_bib0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0005-2728(81)90046-3","article-title":"Phenothiazines and related compounds disrupt mitochondrial energy production by a calmodulin-independent reaction","volume":"637","author":"Ruben","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.06.004_bib0220","first-page":"413","article-title":"The emerging role of m-TOR up-regulation in brain astrocytoma","volume":"32","author":"Ryskalin","year":"2017","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01635588909514000","article-title":"Changes in food intake and stomach contents of tumor-bearing rats after treatment with dopamine antagonists","volume":"12","author":"Sleeman","year":"1989","journal-title":"Nutr. Cancer."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wmts.102","article-title":"L-type Ca(2+) channels in heart and brain","volume":"3","author":"Striessnig","year":"2014","journal-title":"Wiley Interdiscip. Rev. Membr. Transp. Signal."},{"issue":"17","key":"10.1016\/j.critrevonc.2018.06.004_bib0235","first-page":"5399","article-title":"Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine","volume":"50","author":"Strobl","year":"1990","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0240","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006046604062","article-title":"The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide","volume":"51","author":"Strobl","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"8116","key":"10.1016\/j.critrevonc.2018.06.004_bib0245","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(79)91025-0","article-title":"Treatment of metastatic malignant melanoma with pimozide","volume":"1","author":"Taub","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2018.06.004_bib0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/B978-0-12-411546-0.00015-9","article-title":"Emerging treatment strategies in tourette syndrome: what\u2019s in the pipeline?","volume":"112","author":"Termine","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12013-009-9057-4","article-title":"Positive allosteric interaction of structurally diverse T-type calcium channel antagonists","volume":"55","author":"Uebele","year":"2009","journal-title":"Cell. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0922-4106(93)90029-9","article-title":"Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture","volume":"244","author":"Vilner","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.06.004_bib0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/cn5002107","article-title":"Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating ppar\u03b3","volume":"6","author":"Wang","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2018.06.004_bib0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2015.12.013","article-title":"Interventions for tic disorders: an overview of systematic reviews and meta analyses","volume":"63","author":"Yang","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"11","key":"10.1016\/j.critrevonc.2018.06.004_bib0280","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2146\/ajhp070279","article-title":"Association of antipsychotic and antidepressant drugs with Q-T interval prolongation","volume":"65","author":"Zemrak","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"48","key":"10.1016\/j.critrevonc.2018.06.004_bib0285","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.06.004_bib0290","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818300908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818300908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T12:40:57Z","timestamp":1548420057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842818300908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":58,"alternative-id":["S1040842818300908"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.06.004","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}